Prospective evaluation of planar bone scintigraphy, SPECT, SPECT/CT, F-NaF PET/CT and whole body 1.5T MRI, including DWI, for the detection of bone metastases in high risk breast and prostate cancer patients: SKELETA clinical trial.

Autor: Jambor, Ivan1, Aronen, Hannu J.1,2, Kuisma, Anna3, Ramadan, Susan3, Huovinen, Riikka3, Minn, Heikki3,4, Sandell, Minna2, Auren, Joakim2, Saunavaara, Jani2, Kajander, Sami4, Kemppainen, Jukka4, Merisaari, Harri4, Seppänen, Marko4,5, Kauppila, Esa6, Noponen, Tommi5
Zdroj: Acta Oncologica. Jan2016, Vol. 55 Issue 1, p59-67. 9p. 1 Color Photograph, 4 Black and White Photographs, 4 Charts.
Databáze: Academic Search Ultimate